Lupin reported INR63.56B in Operating Expenses for its fiscal quarter ending in September of 2026.





Operating Expenses Change Date
Bharat Petroleum INR 1.42T 151.97B Sep/2026
Cipla INR 63.61B 1.3B Sep/2026
Divis Laboratories Ltd INR 22.52B 3.01B Sep/2026
Dr.Reddys Laboratories INR 74.82B 2.93B Sep/2026
Sun Pharmaceuticals INR 122.92B 5.49B Sep/2026
UPL INR 103.67B 8.54B Sep/2026